Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial - PubMed
6 hours ago
- #apixaban
- #superficial vein thrombosis
- #venous thromboembolism
- This is a post hoc analysis of the HI-PRO trial examining extended low-dose apixaban for preventing symptomatic superficial vein thrombosis in patients with provoked venous thromboembolism and ongoing risk factors.
- The analysis focuses on the impact of the treatment on superficial vein thrombosis events.
- The referenced POST study highlighted the link between superficial venous thrombosis and venous thromboembolism in a large prospective epidemiological study.